Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system that
causes significant disability and healthcare burden. The treatment of MS has evolved over …

Multiple sclerosis (MS) is the most common neurological immune-mediated disease leading
to disability in young adults. The outcome of the disease is unpredictable, and over time …

Background: Multiple sclerosis (MS) is a complex disease with new drugs becoming
available in the past years. There is a need for a reference tool compiling current data to aid …

Objective Rates of worsening and evolution to secondary progressive multiple sclerosis
(MS) may be substantially lower in actively treated patients compared to natural history …

Importance Radiologically isolated syndrome (RIS) represents the earliest detectable
preclinical phase of multiple sclerosis (MS) punctuated by incidental magnetic resonance …

In this narrative review, we analyze pre-registration and post-marketing data concerning
hepatotoxicity of all disease-modifying therapies (DMTs) available for the treatment of …

Multiple sclerosis (MS) is characterized by progressive neuroinflammation and
neurodegeneration from disease onset that, if left untreated, can result in the accumulation …

Background Therapeutic options for children with multiple sclerosis are scarce.
Teriflunomide is approved in more than 80 countries for the treatment of adults with …

Abstract Purpose of Review This paper will systemically review the risk of infections
associated with current disease-modifying treatments and will discuss pre-treatment testing …

Multiple sclerosis treatment faces tremendous changes as a result of the approval of new
medications. The new medications have differing safety considerations and risks after long …